Security key
36269B105
- Security type / class
- Equity / COM
- Total 13F shares
- 8,058,320
- Total 13F value
- $25,937,773
- Share change
- +2,708,717
- Put/Call ratio
- 49%
- SEC-reported price per share
- $3.22
- Number of holders
- 48
- Value change
- +$9,658,734
- Number of buys
- 34
- Number of sells
- 13
Open additional details 1 more signal available
Report period
Q4 2025
Institutions
48
Top holders
10
GANX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Gain Therapeutics, Inc. SEC filings
Gain Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 36269B105
Recent filing periods:
Ownership snapshot
Top reported holders of GANX - Gain Therapeutics, Inc. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
JONES FINANCIAL COMPANIES...
Disclosed value leader
JONES FINANCIAL COMPANIES...
Comparable rows
0/15
Latest evidence
30 Sep 2025
13F
3/4/5
Highest disclosed value: $1,211,511
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
JONES FINANCIAL COMPANIES LLLP has the largest disclosed position value at $1.21M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens JONES FINANCIAL COMPANIES LLLP's linked filing trail.
Disclosed position value
Top 5
JONES FINANCIAL COMPANIES LLLP
$1.21M
Eric I. Richman
$1.17M
DME Capital Management, LP
$1M
VANGUARD GROUP INC
$945.8K
CITADEL ADVISORS LLC
$661.2K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| JONES FINANCIAL COMPANIES LLLP |
13F
Company
|
—
class O/S missing
|
$1,211,511
676,822 shares
|
— | 30 Sep 2025 |
| Eric I. Richman |
3/4/5
Director
|
—
mixed-class rows
|
$1,174,903
319,458 shares
mixed-class rows
|
— | 24 Jun 2025 |
| DME Capital Management, LP |
13F
Company
|
—
class O/S missing
|
$1,002,050
566,130 shares
|
— | 30 Sep 2025 |
| VANGUARD GROUP INC |
13F
Company
|
—
class O/S missing
|
$945,803
534,352 shares
|
— | 30 Sep 2025 |
| CITADEL ADVISORS LLC |
13F
Company
|
—
class O/S missing
|
$661,197
373,558 shares
|
— | 30 Sep 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
class O/S missing
|
$609,190
344,146 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
48
Shares
8,058,320
Rows available
48
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
38
Q4 2025 holders
48
Holder diff
10
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend